91(4):345–353.
Manuel F. Ugarte-Gil, MD, MSc, & Graciela S. Alarcón, MD, MPH | Issue: May 2021 |
91(4):345–353.
Dr. Pisetsky’s picks for the top research in lupus presented at ACR Convergence 2021.
Progress toward targeted therapy
How to minimize the risks of pregnancy for women with SLE
Hydroxychloroquine (HCQ) therapy may effectively manage systemic lupus erythematosus (SLE) in many patients, but that doesn’t mean patients will take it as often as they should. In fact, results from a recently published study found that about half of SLE patients were not adherent.1 The study was led by Lucy H. Liu, MD, MPH, a…